On one hand, it notably inhibits plasmacytoid DCs from secreting interferon (IFN)-α [25], often resulting in exacerbated or paradoxical psoriasis during TNF-α inhibitor treatment [26]. The gene discussed is TNF; the disease is psoriasis.